Virpax Pharmaceuticals In... (VRPX)

0.27

0.02 (9.76%)

At close: Apr 28, 2025, 12:59 PM

Virpax Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net Income	-12.07M	-13.24M	-17.23M	-16.89M	-15.19M	-13.61M	-15.26M	-18.03M	-21.65M	-22.78M	-18.36M	-14.81M	-12.06M	-8.64M	-7.14M	-6.06M	-4.34M	-4.33M	-3.66M	-3.18M	-3.31M	-2.61M	-1.57M	-787.26K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	134.7K	117.86K	331.16K	476.91K	544.77K	692.68K	647.83K	674.28K	745.03K	747.91K	738.96K	815.69K	974.23K	1.17M	1.46M	1.71M	1.47M	1.26M	956.21K	596.83K	678.15K	556.76K	424.62K	212.31K
Other Working Capital	-5.75M	-4.7M	670.56K	837.75K	5.22M	8.05M	5.17M	5.07M	4.05M	-2.06M	-2.42M	-2.99M	-2.71M	-999.9K	-814.68K	-943.88K	-13.09K	59.73K	-79.73K	8.64K	7.95K	-64.66K	-13.39K	-6.69K
Other Non-Cash Items	72.72K	63.09K	258.65K	476.91K	544.77K	692.68K	647.83K	674.28K	745.03K	747.91K	470.63K	259.98K	79.33K	-43.48K	204.17K	149.84K	153.22K	167.63K	719.76K	1.03M	1.28M	1.25M	575.59K	287.8K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-4.78M	-3.73M	1.86M	837.75K	4.79M	4.51M	3.36M	3.55M	3.06M	831.62K	-2.7M	-3.42M	-3.4M	-2.25M	-202.36K	-42.65K	1.33M	1.41M	847.53K	490.69K	214.97K	-64.66K	-13.39K	-6.69K
Operating Cash Flow	-16.71M	-16.85M	-15.04M	-15.57M	-9.85M	-8.41M	-11.26M	-13.81M	-17.85M	-21.2M	-20.45M	-17.51M	-14.54M	-9.77M	-5.67M	-4.24M	-1.38M	-1.5M	-1.13M	-1.06M	-1.13M	-865.58K	-587.7K	-293.85K
Capital Expenditures	n/a	n/a	-3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.01M	-1.01M	-1.5M	-1.5M	-493.48K	-421.38K	72.1K	72.1K	72.1K	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	5.02M	4.72M	2.1M	453.95K	n/a	n/a	n/a	n/a	n/a	50.88K	-2.97M	-2.97M	-5.19M	-5.29M	-2.27M	-2.27M	-50.88K	n/a	300K	612.5K	925K	925K	625K	312.5K
Financial Cash Flow	9.08M	4.72M	2.1M	453.95K	n/a	n/a	n/a	n/a	n/a	50.88K	36.04M	36.04M	51.33M	51.23M	15.72M	16.26M	1.4M	1.65M	1.47M	1.24M	1.13M	925K	625K	312.5K
Net Cash Flow	-7.63M	-12.14M	-12.93M	-15.12M	-9.85M	-8.41M	-11.26M	-13.81M	-17.85M	-21.15M	15.59M	18.53M	36.79M	41.46M	10.05M	12.02M	13.26K	148.72K	331.24K	177.12K	-6.83K	59.42K	37.3K	18.65K
Free Cash Flow	-16.71M	-16.85M	-15.04M	-15.57M	-9.85M	-8.41M	-11.26M	-13.81M	-17.85M	-21.2M	-20.45M	-17.51M	-14.54M	-9.77M	-5.67M	-4.24M	-1.38M	-1.5M	-1.13M	-1.06M	-1.13M	-865.58K	-587.7K	-293.85K